BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9658184)

  • 21. Establishment of a novel host, high-red yeast that stably expresses hamster NADPH-cytochrome P450 oxidoreductase: usefulness for examination of the function of mammalian cytochrome P450.
    Ohgiya S; Goda T; Hoshino T; Kamataki T; Ishizaki K
    Arch Biochem Biophys; 1997 Jul; 343(2):215-24. PubMed ID: 9224733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cloned yeast NADPH-cytochrome P450 reductase gene in Saccharomyces cerevisiae.
    Murakami H; Yabusaki Y; Sakaki T; Shibata M; Ohkawa H
    J Biochem; 1990 Nov; 108(5):859-65. PubMed ID: 2127933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterologous expression of cytochrome P450 2D6 mutants, electron transfer, and catalysis of bufuralol hydroxylation: the role of aspartate 301 in structural integrity.
    Hanna IH; Kim MS; Guengerich FP
    Arch Biochem Biophys; 2001 Sep; 393(2):255-61. PubMed ID: 11556812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional analysis of CYP2D6.31 variant: homology modeling suggests possible disruption of redox partner interaction by Arg440His substitution.
    Allorge D; Bréant D; Harlow J; Chowdry J; Lo-Guidice JM; Chevalier D; Cauffiez C; Lhermitte M; Blaney FE; Tucker GT; Broly F; Ellis SW
    Proteins; 2005 May; 59(2):339-46. PubMed ID: 15726636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
    Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
    Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Site-Directed Mutagenesis of Cytochrome P450 2D6 and 2C19 Enzymes: Expression and Spectral Characterization of Naturally Occurring Allelic Variants.
    Dong AN; Pan Y; Palanisamy UD; Yiap BC; Ahemad N; Ong CE
    Appl Biochem Biotechnol; 2018 Sep; 186(1):132-144. PubMed ID: 29524040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic mobility of genetically expressed fusion protein between cytochrome P4501A1 and NADPH-cytochrome P450 reductase in yeast microsomes.
    Yamada M; Ohta Y; Sakaki T; Yabusaki Y; Ohkawa H; Kawato S
    Biochemistry; 1999 Jul; 38(29):9465-70. PubMed ID: 10413523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
    Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
    Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NADPH-flavodoxin reductase and flavodoxin from Escherichia coli: characteristics as a soluble microsomal P450 reductase.
    Jenkins CM; Waterman MR
    Biochemistry; 1998 Apr; 37(17):6106-13. PubMed ID: 9558349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
    Dong MS; Yamazaki H; Guo Z; Guengerich FP
    Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetically engineered modification of P450 monooxygenases: functional analysis of the amino-terminal hydrophobic region and hinge region of the P450/reductase fused enzyme.
    Yabusaki Y; Murakami H; Sakaki T; Shibata M; Ohkawa H
    DNA; 1988 Dec; 7(10):701-11. PubMed ID: 3148446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward a systems approach to the human cytochrome P450 ensemble: interactions between CYP2D6 and CYP2E1 and their functional consequences.
    Davydov DR; Davydova NY; Rodgers JT; Rushmore TH; Jones JP
    Biochem J; 2017 Oct; 474(20):3523-3542. PubMed ID: 28904078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular cloning and expression in Saccharomyces cerevisiae of tobacco NADPH-cytochrome P450 oxidoreductase cDNA.
    Yamada T; Imaishi H; Oka A; Ohkawa H
    Biosci Biotechnol Biochem; 1998 Jul; 62(7):1403-11. PubMed ID: 9720224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of aromatase cytochrome P450, 17 alpha-hydroxylase cytochrome P450 and NADPH:P450 reductase on the surface of cells in which they are expressed.
    Amarneh BA; Simpson ER
    Mol Cell Endocrinol; 1996 May; 119(1):69-74. PubMed ID: 8793855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
    Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
    Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phe120 contributes to the regiospecificity of cytochrome P450 2D6: mutation leads to the formation of a novel dextromethorphan metabolite.
    Flanagan JU; Maréchal JD; Ward R; Kemp CA; McLaughlin LA; Sutcliffe MJ; Roberts GC; Paine MJ; Wolf CR
    Biochem J; 2004 Jun; 380(Pt 2):353-60. PubMed ID: 14992686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional expression of fused enzymes between human cytochrome P4501A1 and human NADPH-cytochrome P450 oxidoreductase in Saccharomyces cerevisiae.
    Wittekindt NE; Würgler FE; Sengstag C
    DNA Cell Biol; 1995 Apr; 14(4):273-83. PubMed ID: 7710684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
    Shimada T; Mernaugh RL; Guengerich FP
    Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A genetically engineered P450 monooxygenase: construction of the functional fused enzyme between rat cytochrome P450c and NADPH-cytochrome P450 reductase.
    Murakami H; Yabusaki Y; Sakaki T; Shibata M; Ohkawa H
    DNA; 1987 Jun; 6(3):189-97. PubMed ID: 3109864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of human cytochrome P450 2D6 drug metabolites with recombinant microbes--a comparative study.
    Geier M; Braun A; Emmerstorfer A; Pichler H; Glieder A
    Biotechnol J; 2012 Nov; 7(11):1346-58. PubMed ID: 22930520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.